Amgen Inc. Canadian Depositary Receipt (AMGN)
TSX
Closed
Oct 9, 2026
Day's Range
30.3652 wk Range
23.95Overview - AMGN - Amgen Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
349.99B
P/E (Trailing)
‪24.46‬
PEG Ratio
‪0.37‬
Price / Sales (TTM)
‪8.28‬
Price / Book
‪25.66‬
EV / EBITDA
‪20.71‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪67.24%‬
Operating Margin
‪31.92%‬
Return on Assets
‪8.51%‬
Return on Equity
‪89.06%‬
Ownership
Shares Outstanding
540.60M
Price stats
50-Day Avg
‪29.87‬
200-Day Avg
‪27.12‬
Dividends
Frequency
Quarterly
Market Cap - AMGN - Amgen Inc. Canadian Depositary Receipt
Peers - AMGN - Amgen Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
- AMGNTSXAmgen Inc. Canadian Depositary Receipt304.51BMarket Cap+18.18%52-week change24.46P/E (Trailing)‪67.24%‬Profit Margin
- LLYTSXEli Lilly CDR1.45TMarket Cap+37.24%52-week change37.05P/E (Trailing)‪83.04%‬Profit Margin
- ABBVTSXAbbVie Inc. CDR640.88BMarket Cap+13.80%52-week change69.30P/E (Trailing)‪70.23%‬Profit Margin
- JNJTSXJohnson & Johnson630.04BMarket Cap+26.98%52-week change30.25P/E (Trailing)‪21.48%‬Profit Margin
- ROGTSXRoche Holding AG American Depositary Receipt524.02BMarket Cap+20.55%52-week change22.31P/E (Trailing)‪73.72%‬Profit Margin
- MRKTSXMerck & Co., Inc.509.66BMarket Cap+46.01%52-week change118.14P/E (Trailing)‪74.80%‬Profit Margin
- GILDTSXGilead Sciences Inc. Canadian Depositary Receipt243.85BMarket Cap+15.67%52-week change17.00P/E (Trailing)‪78.82%‬Profit Margin
Profile Summary - AMGN - Amgen Inc. Canadian Depositary Receipt
About
Amgen Inc. Canadian Depositary Receipt (CDR) is a financial instrument that provides Canadian investors with exposure to Amgen Inc., a leading biotechnology company focused on developing innovative human therapeutics. This CAD-hedged CDR represents fractional ownership of Amgen Inc. common stock through a dynamic CDR…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
